Chemed Reconciled Depreciation from 2010 to 2026

CXM Stock  EUR 358.00  12.00  3.47%   
Chemed's Reconciled Depreciation is increasing over the last several years with slightly volatile swings. Reconciled Depreciation is predicted to flatten to about 59.1 M. During the period from 2010 to 2026 Chemed Reconciled Depreciation regressed destribution of quarterly values had coefficient of variationof  26.30 and r-value of  0.91. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2020-03-31
Previous Quarter
16.2 M
Current Value
16.3 M
Quarterly Volatility
791.1 K
 
Covid
 
Interest Hikes
Check Chemed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemed's main balance sheet or income statement drivers, such as Interest Expense of 2.3 M, Selling General Administrative of 352.2 M or Total Revenue of 2.2 B, as well as many indicators such as . Chemed financial statements analysis is a perfect complement when working with Chemed Valuation or Volatility modules.
  
This module can also supplement various Chemed Technical models . Check out the analysis of Chemed Correlation against competitors.
The Reconciled Depreciation trend for Chemed offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Chemed is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Chemed's Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of Chemed over the last few years. It is Chemed's Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemed's overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
       Timeline  

Chemed Reconciled Depreciation Regression Statistics

Arithmetic Mean46,570,199
Geometric Mean45,106,178
Coefficient Of Variation26.30
Mean Deviation11,368,704
Median38,863,000
Standard Deviation12,248,200
Sample Variance150T
Range29.2M
R-Value0.91
Mean Square Error28T
R-Squared0.82
Slope2,202,777
Total Sum of Squares2400.3T

Chemed Reconciled Depreciation History

202659.1 M
202564.8 M
202463 M
202360.9 M
202259.2 M
202159.1 M
202056.6 M

About Chemed Financial Statements

Chemed stakeholders use historical fundamental indicators, such as Chemed's Reconciled Depreciation, to determine how well the company is positioned to perform in the future. Although Chemed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Chemed's assets and liabilities are reflected in the revenues and expenses on Chemed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Chemed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Reconciled Depreciation64.8 M59.1 M

Currently Active Assets on Macroaxis

Other Information on Investing in Chemed Stock

Chemed financial ratios help investors to determine whether Chemed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chemed with respect to the benefits of owning Chemed security.